Pavia, Italy

Mauro Freccero

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Acs Dobfar S.p.a.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mauro Freccero. Retrieved from https://idiyas.com/inventor/mauro-freccero

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mauro Freccero: Innovator in Heterocyclic Compounds

Introduction

Mauro Freccero is a notable inventor based in Pavia, Italy. He has made significant contributions to the field of chemistry, particularly in the development of new compounds that have practical applications in pharmaceuticals. His work focuses on the synthesis of heterocyclic compounds, which are essential in the production of various medicinal products.

Latest Patents

Mauro Freccero holds a patent for 1,3 imidazolidine derivatives and their use in the production of carbapenem. This patent details the preparation of new heterocyclic compounds characterized by a 1,3-imidazolidine structure. These compounds are particularly useful for the stereoselective synthesis of optically pure key intermediates in the production of β-methylcarbapenem.

Career Highlights

Freccero is associated with Acs Dobfar S.p.a., where he applies his expertise in chemical synthesis and innovation. His work has contributed to advancements in the pharmaceutical industry, particularly in the development of antibiotics and other critical medications.

Collaborations

Mauro Freccero has collaborated with notable colleagues such as Giovanni Fogliato and Antonio Manca. These collaborations have enhanced the research and development efforts within their field, leading to innovative solutions and discoveries.

Conclusion

Mauro Freccero's contributions to the field of chemistry and his innovative patent in the synthesis of heterocyclic compounds highlight his role as a significant inventor. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…